{
    "organizations": [],
    "uuid": "9849dcc52e96ec272cc33da2199b7302340f0d55",
    "author": "",
    "url": "https://www.reuters.com/article/brief-recro-pharma-estimates-cash-and-ca/brief-recro-pharma-estimates-cash-and-cash-equivalents-about-64-mln-as-of-dec-31-idUSFWN1PX191",
    "ord_in_thread": 0,
    "title": "BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 7, 2018 / 12:39 PM / Updated 10 minutes ago BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31 Reuters Staff 1 Min Read \nFeb 7 (Reuters) - Recro Pharma Inc: \n* RECRO PHARMA - ESTIMATES THAT AS OF DEC 31, 2017, CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $64.0 MILLION Source text for Eikon: ( bit.ly/2nOPGN7 ) Further company coverage:",
    "published": "2018-02-07T14:39:00.000+02:00",
    "crawled": "2018-02-07T14:52:43.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "estimate",
        "cash",
        "cash",
        "equivalent",
        "mln",
        "dec",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "recro",
        "pharma",
        "inc",
        "recro",
        "pharma",
        "estimate",
        "dec",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}